skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 30  for All Library Resources

Results 1 2 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
Material Type:
Article
Add to My Research

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

The New England journal of medicine, 2022-11, Vol.387 (20), p.1855-1864 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2211023 ;PMID: 36342163

Full text available

2
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
Material Type:
Article
Add to My Research

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

The Lancet (British edition), 2015-06, Vol.385 (9984), p.2288-2295 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 6, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61943-7 ;PMID: 25769361 ;CODEN: LANCAO

Full text available

3
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE
Material Type:
Article
Add to My Research

Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE

Circulation (New York, N.Y.), 2023-04, Vol.147 (16), p.1192-1203 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circulationaha.122.063399 ;PMID: 36779348

Full text available

4
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial
Material Type:
Article
Add to My Research

Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial

Journal of the American College of Cardiology, 2016-03, Vol.67 (10), p.1145-1154 [Peer Reviewed Journal]

American College of Cardiology Foundation ;2016 American College of Cardiology Foundation ;Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 15, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.12.062 ;PMID: 26965534

Full text available

5
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial
Material Type:
Article
Add to My Research

Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial

Journal of the American Heart Association, 2021-09, Vol.10 (17), p.e020446-e020446 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.120.020446 ;PMID: 34423649

Full text available

6
The StrongWomen-Healthy Hearts Program: Reducing Cardiovascular Disease Risk Factors in Rural Sedentary, Overweight, and Obese Midlife and Older Women
Material Type:
Article
Add to My Research

The StrongWomen-Healthy Hearts Program: Reducing Cardiovascular Disease Risk Factors in Rural Sedentary, Overweight, and Obese Midlife and Older Women

American journal of public health (1971), 2009-07, Vol.99 (7), p.1271-1277 [Peer Reviewed Journal]

2009 INIST-CNRS ;Copyright American Public Health Association Jul 2009 ;American Public Health Association 2009 ;ISSN: 0090-0036 ;EISSN: 1541-0048 ;DOI: 10.2105/AJPH.2008.145581 ;PMID: 19443826 ;CODEN: AJPEAG

Full text available

7
Changes in physical activity after building a greenway in a disadvantaged urban community: A natural experiment
Material Type:
Article
Add to My Research

Changes in physical activity after building a greenway in a disadvantaged urban community: A natural experiment

Preventive medicine reports, 2019-09, Vol.15, p.100941-100941, Article 100941 [Peer Reviewed Journal]

The Authors ;2019 The Authors ;2019 The Authors 2019 ;ISSN: 2211-3355 ;EISSN: 2211-3355 ;DOI: 10.1016/j.pmedr.2019.100941 ;PMID: 31338283

Full text available

8
Changes in diet and physical activity resulting from the Shape Up Somerville community intervention
Material Type:
Article
Add to My Research

Changes in diet and physical activity resulting from the Shape Up Somerville community intervention

BMC pediatrics, 2013-10, Vol.13 (1), p.157-157, Article 157 [Peer Reviewed Journal]

COPYRIGHT 2013 BioMed Central Ltd. ;COPYRIGHT 2013 BioMed Central Ltd. ;2013 Folta et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2013 Folta et al.; licensee BioMed Central Ltd. 2013 Folta et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2431 ;EISSN: 1471-2431 ;DOI: 10.1186/1471-2431-13-157 ;PMID: 24093936

Full text available

9
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial
Material Type:
Article
Add to My Research

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

Circulation (New York, N.Y.), 2016-07, Vol.134 (1), p.24-36 [Peer Reviewed Journal]

2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.022361 ;PMID: 27358434

Full text available

10
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
Material Type:
Article
Add to My Research

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease

Circulation (New York, N.Y.), 2022-10, Vol.146 (15), p.1109-1119 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.061620 ;PMID: 36031810

Full text available

11
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial
Material Type:
Article
Add to My Research

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial

Circulation (New York, N.Y.), 2020-04, Vol.141 (15), p.1227-1234 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.044183 ;PMID: 31983236

Full text available

12
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
Material Type:
Article
Add to My Research

Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER

Circulation (New York, N.Y.), 2018-08, Vol.138 (8), p.756-766 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.034309 ;PMID: 29626068

Full text available

13
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
Material Type:
Article
Add to My Research

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

European heart journal, 2019-05, Vol.40 (19), p.1541-1550 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019 ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehy861 ;PMID: 30624719

Full text available

14
Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70
Material Type:
Article
Add to My Research

Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70

Circulation (New York, N.Y.), 2022-05, Vol.145 (18), p.1377-1386 [Peer Reviewed Journal]

2022 The Authors. 2022 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.059266 ;PMID: 35369705

Full text available

15
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial
Material Type:
Article
Add to My Research

Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial

Circulation (New York, N.Y.), 2019-11, Vol.140 (22), p.1792-1801 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.041346

Full text available

16
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease
Material Type:
Article
Add to My Research

LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease

Arteriosclerosis, thrombosis, and vascular biology, 2021-12, Vol.41 (12), p.3005-3014 [Peer Reviewed Journal]

ISSN: 1079-5642 ;EISSN: 1524-4636 ;DOI: 10.1161/ATVBAHA.120.315757 ;PMID: 34706556

Full text available

17
Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial
Material Type:
Article
Add to My Research

Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial

Journal of the American College of Cardiology, 2022-08, Vol.80 (9), p.887-897 [Peer Reviewed Journal]

ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2022.05.051

Full text available

18
Decision-Making During Percutaneous Coronary Intervention Guided by Optical Coherence Tomography: Insights From the LightLab Initiative
Material Type:
Article
Add to My Research

Decision-Making During Percutaneous Coronary Intervention Guided by Optical Coherence Tomography: Insights From the LightLab Initiative

Circulation. Cardiovascular interventions, 2022-11, Vol.15 (11), p.872-881 [Peer Reviewed Journal]

2022 The Authors. 2022 ;ISSN: 1941-7640 ;EISSN: 1941-7632 ;DOI: 10.1161/CIRCINTERVENTIONS.122.011851 ;PMID: 36378739

Full text available

19
Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention
Material Type:
Article
Add to My Research

Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention

Circulation. Cardiovascular interventions, 2022-03, Vol.15 (3), p.e011382-e011382 [Peer Reviewed Journal]

ISSN: 1941-7640 ;EISSN: 1941-7632 ;DOI: 10.1161/CIRCINTERVENTIONS.121.011382 ;PMID: 35209731

Full text available

20
Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors
Material Type:
Article
Add to My Research

Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors

Clinical cardiology (Mahwah, N.J.), 2022-07, Vol.45 (7), p.794-801 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals, LLC. ;2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0160-9289 ;EISSN: 1932-8737 ;DOI: 10.1002/clc.23844 ;PMID: 35715946

Full text available

Results 1 - 20 of 30  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (29)

Refine My Results

Creation Date 

From To
  1. Before 2013  (2)
  2. 2013 To 2015  (4)
  3. 2016 To 2017  (3)
  4. 2018 To 2020  (9)
  5. After 2020  (13)
  6. More options open sub menu

Searching Remote Databases, Please Wait